Help oversee talent in skills competition

Sign up to be a workshop supervisor at WorldSkills London 2011

WorldSkills London 2011 is recruiting manufacturing professionals from across the country to oversee the best young talent at the largest skills competition in the world.

Bringing together 1,000 young people from across the globe, the event see will the youngsters compete for medals in 45 categories across six sectors, including manufacturing (and engineering) technology, construction and building technology and transportation and logistics.

WorldSkills London 2011 takes place from 5-8 October at ExCeL London and manufacturing professionals are needed to help as workshop supervisors, who will be responsible for the preparation of materials, health and safety, security and workshop upkeep. They will also support the international judging panel as they test the competitors.

Signing up for the job requires a commitment of approximately one day per month for the next year, increasing to two or three days a month in the six months leading up to the competition and full-time for 10-12 days during the competition. Accommodation, expenses and a remuneration package are available to those who sign up.

Executive director of WorldSkills London 2011, Aidan Jones said: ‘Skills shape our world and workshop supervisors will play an essential role in this massive demonstration of the next generation of talent.’

You may also like

Regulatory

MoonLake Immunotherapeutics faces Securities Class Action after disastrous Phase III trial results

The announcement about the trial results for the product candidate sonelokimab, a highly anticipated treatment for patients with skin disease, saw MoonLake investors' shares fall by about 90%, prompting an investigation into whether or not they were misled
Finance

Novo Nordisk acquires rights to Omeros’ MASP-3 inhibitor zaltenibart in $2.1bn deal

The agreement grants Novo Nordisk exclusive global rights to develop and commercialise the clinical-stage antibody for rare blood and kidney disorders, strengthening its Rare Disease portfolio
Finance

Kailera Therapeutics secures $600m in Series B financing to advance next-generation obesity therapies

The funding will support the advancement of Kailera’s obesity portfolio, including a global Phase III clinical programme of Kailera’s lead candidate KAI-9531, an injectable dual GLP-1/GIP receptor agonist with potentially best-in-category weight loss
Finance

LTS expands CDMO footprint with acquisition of Renaissance Lakewood

LTS Lohmann Therapie-Systeme has agreed to acquire US-based CDMO Renaissance Lakewood, strengthening its position in nasal spray and sterile dosage form manufacturing and broadening its global drug delivery capabilities
Finance

Nanoform collaborates with A.forall and IMGA to outlicence Nanoencorafenib

Nanoform will establish a new company, BRAFMed, to progress the clinical development and future outlicensing of the patient-centric nanoformulation of encorafenib
Manufacturing

Gerresheimer adjusts 2025 guidance amid slower market growth

Transformation program launched to boost performance and free cash flow
Manufacturing

AstraZeneca strikes deal with US government to cut drug prices and boost domestic manufacturing

AstraZeneca has reached an agreement with the Trump administration to lower medicine costs, pledging $50bn in US manufacturing and R&D investment, whilst safeguarding the nation’s biopharma innovation leadership
Subscribe now